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The ability to engineer cardiac tissue in vitro is
limited by the absence of a vasculature. In this study we
describe an in vivo model which allows neovascularization
of engineered cardiac tissue. Three-dimensional cardiac tis-
sue, termed “cardioids,” was engineered in vitro from the
spontaneous delamination of a confluent monolayer of car-
diac cells. Cardioids were sutured onto a support frame-
work and then implanted in a subcutaneous pocket in
syngeneic recipient rats. Three weeks after implantation,
cardioids were recovered for in vitro force testing and his-
tological evaluation. Staining for hematoxylin and eosin
demonstrated the presence of viable cells within explanted
cardioids. Immunostaining with von Willebrand factor
showed the presence of vascularization. Electron micro-
graphs revealed the presence of large amounts of aligned
contractile proteins and a high degree of intercellular con-
nectivity. The peak active force increased from an average









explanted cardioids. There was also a significant increase
in the specific force. There was a significant decrease in the
time to peak tension and half relaxation time. Explanted
cardioids could be electrically paced at frequencies of 1–
5 Hz. Explanted cardioids exhibited a sigmoidal response
to calcium and positive chronotropy in response to
epinephrine. As the field of cardiac tissue engineering
progresses, it becomes desirable to engineer larger diame-
ter tissue equivalents and to induce angiogenesis within
tissue constructs. This study describes a relatively simple in
vivo model, which promotes the neovascularization of tis-
sue-engineered heart muscle and subsequent improvement








Heart disorders remain a global epidemic with
constantly  increasing  mortality  rates  (1).  There is
an unprecedented need to develop new treatment
options. Cardiac tissue engineering may provide a
new treatment option by generating cardiac tissue in
vitro. Tissue-engineered heart muscle can be utilized
to treat cases of myocardial infarction and for the
repair of congenital heart defects. In addition to
potential clinical applicability, a cardiac tissue analog
may be used in drug development and as a model to
study the process of in vitro self-organization that
could provide insight into cardiac developmental
biology.
There have been several strategies utilized to engi-
neer cardiac tissue in vitro. Temperature sensitive
surfaces have been used to manufacture two-dimen-
sional sheets of cardiac myocytes. These sheets have
been stacked together to form three-dimensional
cardiac muscle (2–4). Synthetic scaffolds have been
fabricated from polyglycolic acid and have been
seeded with neonatal cardiac myocytes to engineer
cardiac tissue equivalents (5–7). In addition, various
biodegradable  gel  systems  consisting  of  gelatin
(8–10), alginate (11), and collagen (12–15) have been
utilized.
We have developed a method to engineer three-
dimensional cardiac tissue constructs and have
termed the resulting tissue analog, a “cardioid” (16).
Cardioids result from the spontaneous delamination
of a confluent monolayer of neonatal cardiac myo-
cytes plated on a culture surface treated to control
cell adhesion. Cardioids generate an active force of




N upon electrical stimulation. In addition,
cardioids can be electrically paced at physiologi-
cally relevant frequencies of 1–5 Hz without notable
fatigue. Cardioids also exhibit an increase in force
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production in response to ionic calcium and positive
chronotropy in response to epinephrine.
The ability to maintain long-term viability of car-
dioids is limited by the lack of a vasculature within
the three-dimensional tissue construct. The lack of a
vasculature limits oxygen diffusion to the cells within
the inner core of the cardioid resulting in the loss of
cell viability. It therefore becomes imperative to
promote neovascularization within the avascular
cardioids.
There have been several studies describing ang-
iogenesis models for engineered cardiac tissue
(4,10,11,17). Cardiac tissue constructs have been
engineered in vitro and then implanted in recipient
animals to promote neovascularization. The target
site for implantation has varied between studies and
can be a subcutaneous pocket (4,17), or the host
myocardium (10,11). In both cases, survival of the
tissue equivalents has been demonstrated along with
a vast amount of neovascularization. Although these
studies serve to demonstrate the successful neovas-
cularization of engineered cardiac tissue constructs,
there is very little information about the changes in
contractility resulting from neovascularization.
The objective of this study was to investigate the
effect of an in vivo environment on the contractile
performance of tissue-engineered heart muscle. We
describe a subcutaneous implantation model which
promotes the neovascularization of cardioids over a
period of 3 weeks. We obtained significant improve-





Approval for animal use was granted by the Uni-
versity Committee for the Use and Care of Animals
(UCUCA) in accordance with the “Guide for the
Care and Use of Laboratory Animals” (NIH publi-
cation 86-23, 1986). All materials were purchased
from Sigma (St. Louis, MO, U.S.A.) unless otherwise
specified.
 
Isolation of neonatal cardiac myocytes
 
Cardiac myocytes were isolated from 2- to 3-day-
old F344 rat hearts using an established method (18).
Briefly, neonatal pups were decapitated and an inci-
sion made along the chest cavity to expose the hearts
which were excised and placed on ice. The hearts
were cut into fine pieces and suspended in a dissoci-
ation solution (DS) which consisted of 0.32 mg/mL
collagenase type II (Worthington Biochemical Cor-
poration, Lakewood, NJ, U.S.A.) and 0.6 mg/mL pan-
creatin dissolved in a buffer consisting of 116 mM








, 5.5 mM glu-










C and the supernatant was collected in 5 mL of
horse serum (Invitrogen Corporation, Auckland,
New Zealand). Cells from all the digests were
pooled, centrifuged and then suspended in plating
medium (PM) consisting of 335 mL DMEM, 85 mL
M199, 25 mL fetal bovine serum, 50 mL horse serum,
5 mL antibiotic-antimycotic (Invitrogen Corpora-
tion, Auckland, New Zealand). The final cell concen-










Preparation of the plates
 
The detailed method for preparing the culture
surface for engineering cardiac muscle has been
described in detail (16). Briefly, 35-mm culture plates
were coated with 1.5 mL of a polydimethylsiloxane
(PDMS) elastomer (Dow Chemical Corporation,
Midland, MI, U.S.A.). The PDMS surface was subse-




g/cm (2) of natural mouse
laminin (Invitrogen Corporation, Carlsbad, CA,
U.S.A.). Anchor points were engineered on the lami-
nin coated surface by placing 6 mm long segments of
size 0 braided silk sutures (Ethicon, Cornelia, GA,




g/mL laminin and pinned
12 mm apart in the center of the culture surface. Two









were plated onto each 35-mm culture surface and









a period of 3 days, PM was replaced with growth
medium (GM) consisting of 365 mL DMEM, 100 mL
M199, 35 mL FBS, 5 mL antibiotic-antimycotic
(Invitrogen Corporation, Carlsbad, CA, U.S.A.).
Cardioids were formed within 14 days of initial cell
plating.
 
Implantation and explantation of cardioids
 
Laser-cut elliptical acrylic frames were fabricated
using a 120 W Laser Engraving Machine (Applied
Laser Systems, Pasadena, CA, U.S.A.) from cast clear
acrylic poly (methyl methacrylate) sheet. Isogeneic
adult F344 rats (Charles River Laboratories,
Wilmington, MA, U.S.A.) were anesthetized by an
intraperitoneal injection of 0.5 mL of sodium pento-
barbital (Abbott Laboratories, Chicago, IL, U.S.A.),
shaved,  prepped,  and  a  pocket  was dissected under
the panniculus carnosus. Cardioids were secured to
the frame with 8-0 nylon sutures (Ethicon). The
frame with the cardioids was placed in the subcu-
taneous pocket and secured to the underlying mus-
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cular fascia (Fig. 1A) with 6-0 polypropylene sutures
(Ethicon). The incision was then closed with 4-0
nylon sutures (Ethicon). The animals were returned
to an approved facility for recovery and were housed
at  this  facility  for  a  period  of  3 weeks.  A  total  of
six cardioids were implanted in this manner. To
recover implanted cardioids, host rats were anesthe-
tized and the previous incision was re-entered. The
cardioids were removed from the surrounding tissue.
The cardioids were removed from the elliptical frame
and pinned to a 35-mm tissue culture plate coated
with PDMS. The animals were euthanized by an
overdose of sodium pentobarbital and subsequent
removal of the heart. The contractility of the
explanted cardioids was evaluated immediately upon
recovery. As controls, six cardioids were engineered
in vitro and were tested 2 days after complete forma-
tion. One control cardioid was lost due to contami-
nation. The remaining five control cardioids were
processed for in vitro force testing and histological





The method for evaluating the contractility of
engineered cardiac muscle has been described in
detail (16). Briefly, the cardioids were stimulated
between parallel platinum electrodes and the active
force was measured using a custom built optical force
transducer (Fig. 1B). An electrical impulse of magni-
tude 5 V with a pulse width of 10 ms and a frequency
of 1 Hz was used. The active force was measured
using a custom made optical force transducer and
force tracings were digitally recorded using Lab-
VIEW (National Instruments Corporation, Austin,
TX, U.S.A.). The length of each cardioid was
adjusted using a micromanipulator to optimize the
force generated. The peak active force was normal-
ized to the total cross-sectional area of the cardioid
to obtain the specific force. The cross-sectional area
of the cardioids was calculated from the construct
diameter which was determined by a calibrated eye-





We electrically paced the explanted and control
cardioids by varying the stimulation frequency
between 1 and 5 Hz, while maintaining all other stim-
ulation parameters.
The twitch force and the pacing characteristics were
determined for all six explanted cardioids and five
control cardioids. The six explanted cardioids were
then divided into two groups of three cardioids for
further testing. The first group was used for the eval-
uation of contractility, calcium sensitivity behavior,
responsiveness to epinephrine and the length–force
relationship. The second group was used for detailed
histological evaluation. The control cardioids were
also divided into two groups with two cardioids being




Implantation model for engineered cardiac tissue. (a)
Cardioids (C) were engineered in vitro and were attached to
acrylic support frame (F) using sutures (S) and then implanted
subcutaneously. (b) Three weeks after implantation, the cardioids
were recovered and pinned using 0.1-mm minutien pins (M) to a
35-mm tissue culture surface coated with PDMS. The cardioids
were electrically stimulated between parallel platinum electrodes
(not shown) and the active force was recorded using an optical
force transducer (FT). (c) High magnification image of a postim-
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to epinephrine and length–force data and three car-
dioids being used for histological evaluation.
To evaluate the effect of external calcium on










acid (EGTA) were added to the bath to bind residual
stores of calcium in the cardioids. Calcium was grad-
ually added to the testing bath and stimulated con-
traction forces were re-evaluated with each addition.
The response of the cardioids to epinephrine was
studied by adding known concentrations of 1 mg/mL
epinephrine (Abbott Laboratories, North Chicago,
IL, U.S.A.) to the GM, with the constructs still
attached to the force transducer. The bath epineph-





The length–force characteristics were evaluated by





m and evaluating the active force at each incre-
ment. Initially, we evaluated the active force of the
explanted cardioid by pinning the construct at length.
We gradually decreased the length of the cardioids




m and evaluated the active
force at each increment. We continued this process
until the active force decreased to a value of 20–30%
of the active force obtained at length. The length of





N and the active force evaluated at each incre-
ment. As the length of the cardioid was increased,
the active force first increased, then reached a pla-
teau and then decreased. We stopped increasing the
length of the cardioids when the active force
decreased to about 20–30% of the maximum active
force. The length at which the cardioids generated








Cardioids were fixed in a 4% paraformaldehyde
solution for 4 h, rinsed in 70% ethanol and stored in
70% ethanol until use. The cardioids were prepared
using a graded ethanol process with an automated
tissue processor (Shandon Hypercenter XP, Thermo
Electron, Waltham, MA, U.S.A.) for 7 h and 36 min.
The cardioids were then paraffin-embedded. The





on a microtome processor and placed on ProbeOn
Plus slides (Fisher Scientific Company, Pittsburgh,
PA, U.S.A.) for immunohistochemistry. Hematoxylin
and eosin staining (H&E) was used for morphologic
analysis. To identify and localize endothelial cells,
immunohistochemical staining for von Willebrand
factor (vWF) was performed. The slides were heated




C for 20 min. The heated slides were
then placed in three changes of xylene, 100% etha-
nol, 95% ethanol, and buffer to prepare for staining.
Antigen retrieval was performed for the slides desig-
nated vWF by applying Proteinase K (DAKO Cyto-
mation, Carpinteria, CA, U.S.A.) for 5 min at room
temperature. The primary antibody vWF antibody,
polyclonal rabbit anti-human (DAKO Cytomation)
was incubated at a dilution of 1:250 at room temper-





(DAKO Cytomation) was used for detection of the
vWF antibody (DAKO Cytomation). Sections were
viewed and photographed using a Nikon Axiophot




The method used for electron microscopy has been
previously described (19). Briefly, cardioids were




C in Karnovsky’s solution consisting
of 0.1 M sodium cacodylate buffer with 3% formal-
dehyde and 3% glutaraldehyde (Electron Micro-
scopy Sciences, Fort Washington, PA, U.S.A.) at
pH 7.4. Cardioids were rinsed three times (30 min,
30 min and 4 h) with cacodylate buffer, pH 7.4 with
7.5% sucrose. Cardioids were postfixed in 1%
osmium tetroxide for 2 h at room temperature, dehy-
drated in graded concentrations of ethanol and pro-
pylene oxide and embedded in EPON, Eponate 12
resin (Ted Pella Inc., Redding, CA, U.S.A.). Embed-
ded specimens were sectioned at 600 nm thick with
a diamond knife on a Sorvall MT-5000 ultramicro-
tome (RMC, Inc., Tuscon, AZ, U.S.A.). Ribbons of
sections were mounted on copper grids, stained with
uranyl acetate and lead citrate and examined using a
Philips CM-100 transmission electron microscope.
Photographs were obtained using a Kodak 1.6 Mega-









-test to evaluate changes
in contractility and responsiveness to epinephrine
resulting from implantation. Minitab V13.31 (State




The gross appearance of the explanted cardioids
was evaluated visually upon recovery. The explanted
cardioids exhibited a high of spontaneous contractil-
ity directly after explantation, which was determined
to be at a frequency of 1–2 Hz. Visual examination
also revealed the presence of superficial capillaries at
multiple sites along the length of the cardioids. This
was evident in all six of the explanted cardioids.
Histological evaluation of cardioids consisted of
staining with H&E, staining for vWF and transmis-
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sion electron microscopy. Neovascularization was
macroscopically evident in postimplantation cardio-
ids (Fig. 1C). H&E staining revealed the presence of
viable cells throughout the explanted tissue con-
structs (Fig. 2A). Staining for vWF showed the pres-
ence of a significant amount of endothelial cells that
had organized to form luminal structures throughout
the explanted cardioids (Fig. 2B). Transmission elec-
tron micrographs showed the presence of a very large
amount of contractile proteins arranged in a hexag-
onal array. There was also a high degree of intercel-
lular connectivity and the presence of intercalated
discs was evident. A large amount of mitochondria
were found to be associated with the myofilaments
(Fig. 3).
We evaluated the contractile properties of the
cardioids  and  the  active  force  and  specific  force
were determined (Fig. 4). The peak active force for

























 5) for control cardi-
oids (Fig. 4A). The maximum force generated by a





N for a single control cardioid. The average









with a maximum value of 14.9 kPa for explanted car-
dioids (Fig. 4B). The average specific force for con-









with a maximum value of 2.3 kPa.
The cardioids were electrically paced at frequen-




Immunohistochemistry of explanted cardioids. (A) Stain-
ing with hematoxylin and eosin showed the presence of viable
cells. (B) von Willebrand staining showed the presence of capil-
laries (single arrows) throughout the tissue section. (C) and (D)
show higher magnification images of hematoxylin and eosin

















Electron micrographs (EM) of explanted cardioids. Cross
section showing the presence of large amounts of myofilaments
(double arrow) with a significant amount of mitochondria (Mito).
Intercalated discs between adjacent myocytes are also evident




Contractility measures for experimental cardioids. (A)

























 5) for control
cardioids. (B) Specific force (active force normalized to total
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completely relax, that is, produce a force of zero,
between active contractions, with the force returning
to baseline values when paced at 1 and 2 Hz. This was
also the case when explanted cardioids were electri-
cally paced at 5 Hz. This was unlike the case for con-
trol cardioids. Control cardioids were able to relax
by only 15% of peak force at a frequency of 1 Hz.
The ability of control cardioids to relax between
active contractions was reduced with increasing pac-
ing frequencies.
We evaluated the responsiveness of cardioids to
external calcium and found that the calcium sensitiv-
ity characteristics of both explanted and control car-
dioids were very similar. In the absence of calcium in
the testing bath, the active force was not different
from baseline noise. However, incremental addition
of exogenous calcium produced a sigmodal increase
in active force (Fig. 5).
The responsiveness of cardioids to epinephrine
was evaluated (Fig. 6). The cardioids exhibited base-
line spontaneous contractility upon explantation
which persisted for the duration of the force testing.
The spontaneous contractility of the cardioids
increased with the incremental addition of epineph-




g/mL of epinephrine initiated
this response and the maximum response was





(Fig. 6A–C). A similar response was observed for
control cardioids, although the increase in spontane-
ous contractility was not as significant (Fig. 6D–F).
This phenomenon was completely reversible. Com-
plete removal of epinephrine from the bath re-
established baseline spontaneous contractility of
cardioids, as evaluated by the frequency of spontane-
ous contractility. A total of three explanted and three
control cardioids were tested in this way (Fig. 6G).
Epinephrine was found to have an increase in the
spontaneous contractility of explanted cardioids.
We evaluated the length–force characteristics of
the cardioids. Increasing the length of the cardioids
resulted in a proportional increase in active force
(Fig. 7). As the length of the cardioid was further
increased, a plateau was reached and a further
increase in length resulted in a proportional decrease




The long-term goal of cardiac tissue engineering is
to generate functional cardiac muscle in vitro. Tissue-
engineered heart muscle may prove to be a valuable
tool in drug testing and as a three-dimensional model
for  basic  cardiology  research.  Various  strategies
have been utilized to generate three-dimensional
cardiac muscle in vitro. Synthetic scaffolds and bio-
degradable gels have been utilized to promote the
formation of cardiac muscle and various self assem-
bly strategies have been successfully implemented as
well. One challenge in engineering functional cardiac
muscle is to promote the formation of new blood
vessels as an intrinsic component of the tissue con-
struct. The blood vessels would act as functional sites
for nutrient exchange thereby promoting the long-
term survival of tissue-engineered cardiac muscle.
We have previously developed a method to engi-
neer three-dimensional cardiac tissue and have
termed the resulting tissue constructs “cardioids”
(16). Cardioids are formed from the spontaneous
delamination of a confluent monolayer of neonatal
cardiac myocytes. Cardioids are electrically excitable





upon electrical stimulation. Cardioids can also be
electrically paced and exhibit physiological responses
to calcium and epinephrine.
An interesting aspect of the cardioid model is the
retention of cardiac fibroblast in the initial cell pop-
ulation. The  purpose  of  the  cardiac  fibroblasts  is
to generate extracellular matrix (ECM) components
which provide mechanical stability during cardioid
formation. This ECM is considered to be a suitable
substrate for the generation of cardiac muscle and




Calcium sensitivity of experimental cardioids. Cardioids
were pinned to a PDMS surface and completely submerged in
calcium free DMEM. Residual calcium was removed by adding
EGTA to the testing bath and fresh calcium free DMEM re-
introduced to the bath. Calcium was incrementally introduced
and the active force evaluated at each incremental addition of
calcium. The procedure was repeated until there was no increase
in active force production upon the addition of calcium. This
procedure was repeated for three explanted and two control
cardioids. The curves shown represent the calcium sensitivity of
a single explanted and a single control cardioid. Values shown
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Responsiveness of experimental cardioids to epinephrine. (A–C) show the behavior of control cardioids and (D–F) show the
behavior of explanted cardioids. All force tracings represent spontaneous contractions. In the case of control cardioids, there was a




g/mL epinephrine increased the frequency to 0.2 Hz




g/mL epinephrine further increased the frequency to 0.4 Hz. In comparison, explanted cardioids had a




g/mL epinephrine. Increasing the epinephrine




g/mL epinephrine caused no further increase in the number of contractions. (G) The responsiveness of three
explanted and three control cardioids was evaluated. The baseline spontaneous contractility increased from 0.35 
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neered construct. An important variable effecting
cardioid formation is the ratio of cardiac fibroblasts
to myocytes. A low percentage of cardiac fibroblasts
will not generate adequate ECM resulting in the for-
mation of mechanically unstable cardioids. A very
high percentage of cardiac fibroblasts will result in a
lower active force due to the lower percentage of
cardiac myocytes. As the cardioid model is more fully
characterized, an optimal ratio of cardiac fibroblasts
to myocytes will need to be identified.
The purpose of this study was to promote the for-
mation of a vasculature within previously engi-
neered cardioids. Cardioids were implanted in a
subcutaneous incision in recipient rats for a period
of 3 weeks and then recovered for in vitro force test-
ing and histological evaluation. The model pre-
sented in this study is closest to the model presented
by Shimizu et al. (4). Shimizu et al. described subcu-
taneous implantation of engineered cardiac tissue
and the constructs were shown to survive for a
period of 3 months (4). Significant neovasculariza-
tion of the implanted constructs was demonstrated
(4). However, the effect of neovascularization on
the contractility of the tissue-engineered cardiac
muscle was not evaluated.
The model presented in this study showed that the
cardioids remained viable and maintained a differen-
tiated phenotype during the implantation period.
The  viability  of  the  cardioids  was  firstly  noted  by
the spontaneous contractility upon recovery. The
viability of the cardioids was further supported by
histological and contractility data. Support for differ-
entiated muscle phenotype came from electron
micrographs which show the presence of myofila-
ments that are characteristic of muscle cells. More
compelling was the presence of the intercalated discs,
which are specific to cardiac myocytes.
The contractility data showed that there was an
improvement in function of cardioids resulting from
subcutaneous implantation. When considering the
contractility metrics of explanted cardioids, it would
be interesting to compare the performance of the
explanted cardioids to control cardioids, to normal
cardiac muscle tissue and to other published models
of tissue-engineered cardiac muscle. The maximum





N while the maximum specific force was cal-
culated to be 14.9 kPa. In comparison, the maximum
active force generated by control cardioids was found




N with a maximum specific force of
4.1 kPa. There was a significant increase in the force
generating capabilities of the cardioids resulting
from implantation. Although the exact mechanism
for the increased force production is not clear, vas-
cularization of the cardioids may be a contributing
factor. Vascularization could promote the survival of
cardiac cells within the tissue-engineered constructs
thereby leading to increased cell viability. In addi-
tion, cardioids are also exposed to systemic signaling
in the host environment which could also modulate
contractile properties.
It would be insightful to compare the force gener-
ating capacity of explanted cardioids to normal myo-
cardial tissue. One of our goals is to develop models
of tissue-engineered cardiac muscle that closely
resemble normal myocardium and incorporation of
a vasculature is an attempt to achieve this. An adult
rat papillary muscle has been shown to generate a




N and a specific force of
44.4 kPa (20). Both the active force and the specific
force for explanted cardioids are significantly lower
than that of an adult papillary muscle. Although
there was an improvement in contractility of control
cardioids resulting from implantation, the force gen-
erating capacity of explanted cardioids was not com-
parable to normal adult cardiac tissue. This could be
due to the early developmental stage of the neonatal
cardiac myocytes utilized in this study. Developmen-
tally immature cardiomyocytes are known to contain
significantly smaller amounts of contractile proteins
per unit cross section of cardiac tissue (21).
It would be interesting to compare the function of
explanted cardioids to other published models of
tissue-engineered heart muscle. There have been




Length–force relationship of experimental cardioids. The
length of each cardioid was optimized for maximum force pro-




 and the force measured





explanted cardioids and two control cardioids, multiple measure-
ments were recorded over a range of adjusted lengths to fully
characterize the length–force relationship. The curve shown is
one of two constructs tested in this manner. Values shown rep-
resent the mean and standard deviation.
Normalized length (% Lo)
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contractile properties of engineered heart tissue
(EHT) have been described in detail. EHTs are gen-
erated by casting a suspension of cardiomyocytes in
a collagen gel (15). EHTs have been shown to gen-




N with a specific force
of 0.4 kPa under basal conditions (15). In compari-
son, the average specific force of control cardioids
was found to be 4.1 kPa and the average specific
force of explanted cardioids was found to be
14.9 kPa. Explanted cardioids generate significantly
higher forces than EHTs. This could be due to the
absence of synthetic scaffolding material in the
contractile region of cardioids, thereby permitting
uninhibited contractions.
There have not been any published studies de-
tailing the changes in contractile properties of
engineered muscle resulting from implantation.
Therefore a direct comparison of explanted cardioids
is not possible at this point.
In order to further characterize cardiac-specific
phenotype, we subjected the cardioids to electrical
pacing by varying the stimulation frequency from 1
to 5 Hz. The explanted cardioids were successfully
paced at the physiologically relevant frequencies
tested. What was most intriguing was the ability of
the explanted cardioids to completely relax between
active contractions. This behavior was unlike the pac-
ing characteristics of the control cardioids, which
were unable to completely return to baseline condi-
tions during active contractions. The ability of the
explanted cardioids to relax to baseline conditions
between active contractions could be due to changes
in  calcium  handling  properties.  An  increase  in




ATPase (SERCA) or a decrease in the amount of
phospholamban could lead to an increase in the rate
of calcium handling in the explanted cardioids. Dur-
ing the course of electrical pacing, we observed a
decrease in the active force with consecutive contrac-
tions for explanted cardioids. This was progressively
more significant with increasing pacing frequencies.
The decrease in active force is indicative of muscle
fatigue and may be due to repetitive contractions of
the vascular cardioid without the active flow of nutri-
ents through the newly formed blood vessels.
In order to further characterize the phenotype of
the explanted cardioids, we evaluated the respon-
siveness to external calcium, the responsiveness to
the cardio-active drug epinephrine and determined
the length–force relationship. We found that the
explanted cardioids exhibited a sigmodal response
to external calcium. The responsiveness to calcium
was very similar to normal cardiac tissue and shows
the presence of functional calcium handling pro-
perties. The explanted cardioids exhibited an
increase in chronotropy in response to epinephrine.
The increase in chronotropy could be due to the
increased calcium handling properties of the
explanted cardioids and provide further support for
a cardiac-specific phenotype. The final metric that
we evaluated was the length–force curve. Note from
Fig. 7 that the active length–tension curve from the
explanted cardioids is narrower than the length–
tension curve from the cardioids grown in culture.
We hypothesize that this is due to improved struc-
tural organization both within and between the car-
diomyocytes in the explanted cardioids. Specifically,
we hypothesize that within the explanted cardioids
the sarcomeres are more fully in register and have
functional structures for the lateral transmission of
force between adjacent cardiomyocytes, further
retaining the registration of the contractile appara-




In this study we describe a model for the vascular-
ization of cardioids and subsequent improvement in
contractile metrics. The model consists of securing
cardioids in a subcutaneous pocket in recipient rats
for 3 weeks. Histological data showed the presence
of vascularization throughout the cardioids. Electron
micrographs provided evidence for the differentiated
phenotype of the explanted cardioids. Contractility
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